Sequani invests in people and facilities as it eyes future growth

As part of their strategic plans for growth and to meet the evolving needs of modern product developers, Ledbury-based Contract Research Organisation, Sequani has made a significant investment in a new custom designed facility incorporating 820m2 of laboratory space and a 910m2 modern vivarium, whilst also appointing Lee Coney as CSO.

With over 30 years’ of product development and senior managerial experience in the sector, Lee will take a leading role in working with the company’s customers to develop a wide range of pharmaceutical, crop protection and chemical products.

Speaking about the new facility, Lee said: “The new state-of-the-art lab and vivarium will enable us to be more flexible and allow us to support the evolving needs of our customers and worldwide regulatory authorities.

“Amongst other advantages, co-locating the laboratory and animal facilities into a single building offers enhanced biosecurity for sample flows from animal unit to analytical laboratory. It’s more efficient and will allow us to deliver a superior service.”

The new facility has flexibility at its core, allowing Sequani to work with a wider range of novel products. As the greater part of GLP non-clinical safety testing is performed in Contract Research Organisations it is critical that laboratories adapt to the changing needs of their customers.

Commenting on the new facility and CSO appointment, Sequani CEO, Stephen Eckley said: “I am very proud of the decisions we have made as we look to the future. As a business we have always challenged ourselves to lead from the front. The advances we are making as we support our customers to protect human health bear testament to that.

“Non-clinical safety assessment used to be a prescriptive business but that’s no longer the case. We work with a wide range of organisations in the pharmaceutical, crop protection and chemical industries. It’s vital that we keep abreast of developments in the field and understand how this impacts our customers.

“Lee’s appointment comes at a pivotal time and, working with our highly experienced team of talented technologists and scientists, he will ensure that we continue to increase our capabilities, knowledge and experience across a wide range of analytical areas.”

Sequani is attending SOT in Salt Lake City from March 10th – 14th. For more information, visit For more information, visit

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

Related news